ArriVent Biopharma

Arri Vent Biopharma

Biotechnology, 18 Campus BLVD Ste 100, Newtown Square, Pennsylvania, 19073, United States, 11-50 Employees

arrivent.com

  • facebook
  • LinkedIn

Who is ARRIVENT BIOPHARMA

ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products. With a deep and global network, ArriVent seeks to access unique and best-in-class dr...

Read More

map
  • 18 Campus BLVD Ste 100, Newtown Square, Pennsylvania, 19073, United States Headquarters: 18 Campus BLVD Ste 100, Newtown Square, Pennsylvania, 19073, United States
  • 2021 Date Founded: 2021
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ARRIVENT BIOPHARMA

ArriVent Biopharma Org Chart and Mapping

Employees

Miki Yamamoto

Sr Vice President, Head of Regulatory Affairs

Wanda Kwan

Senior Program and Alliance Manager

John Le

Associate Director Clinical Research

Nichole Baio

Associate Director Clinical Operations

Shirley Wang

Director, Biostatistics

Dandan Dong

Chief Business Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding ArriVent Biopharma

Answer: ArriVent Biopharma's headquarters are located at 18 Campus BLVD Ste 100, Newtown Square, Pennsylvania, 19073, United States

Answer: ArriVent Biopharma's official website is https://arrivent.com

Answer: ArriVent Biopharma's revenue is $10 Million to $25 Million

Answer: ArriVent Biopharma's SIC: 2834

Answer: ArriVent Biopharma's NAICS: 325412

Answer: ArriVent Biopharma has 11-50 employees

Answer: ArriVent Biopharma is in Biotechnology

Answer: ArriVent Biopharma contact info: Phone number: Website: https://arrivent.com

Answer: ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products. With a deep and global network, ArriVent seeks to access unique and best-in-class drug candidates at various development stages, including those coming from China and other emerging biotech hubs. Through strategic collaborations with innovative biopharma companies, ArriVent aims to globalize medicines for patients with unmet medical need in a broad range of diseases, with an initial focus in oncology.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access